Journals / Retina-Vitreus / 2012 / Cilt: 20 - Sayı: 1

Juxtafoveal telangiectasis

Jukstafoveal telenjiektaziler

Pages
1–12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study we aimed to evaluate new classifications and therapeutic approaches in JFT patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Juxtafoveolar telangiectasis (JFT), although described as ‘telangiectasia’are a heterogeneous group of disorder mainly consisting of 3 subgroups which differ from each other by clinical aspects.
📊
Key Findings & Data:Classification studies have shown that only type 1 JFT group presents true telangiectatic changes, while type 2 JFT is presenting foveal atrophy and choroidal neovascularization.
💡
Conclusion & Impact:In this study we aimed to evaluate new classifications and therapeutic approaches in JFT patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Juxtafoveolar telangiectasis (JFT), although described as ‘telangiectasia’are a heterogeneous group of disorder mainly consisting of 3 subgroups which differ from each other by clinical aspects. Classification studies have shown that only type 1 JFT group presents true telangiectatic changes, while type 2 JFT is presenting foveal atrophy and choroidal neovascularization. The clinical presentation of type 3 JFT is capillary occlusion and macular ischemia. The clinical and imaging findings are different among the three subtypes, therefore treatment strategies are addressed differently, too. In this study we aimed to evaluate new classifications and therapeutic approaches in JFT patients.

Özet

Jukstafoveal telenjiektaziler (JFT), ‘telenjiektazi’olarak tarif edilmiş olmakla beraber heterojen bir hastalık grubudur ve 3 ana grupta incelenmektedir. Yapılan çeşitli sınıflamalar ve araştırmalar sonucunda Tip 1 JFT’nin, gerçek telenjiektatik değişiklikler içeren hastaları, tip 2 JFT foveal atrofi ile seyreden ve koroid neovaskülarizasyonu ile komplike olabilen hastaları, tip 3 JFT ise kapiller oklüzyon ve maküler iskemiyle seyreden hastaları temsil ettiği anlaşılmıştır. 3 tipin muayene ve görüntüleme bulguları, klinik seyirleri tamamen farklı olduğu için tedavileri de farklı olarak ele alınmaktadır. Bu çalışmada yeni JFT sınıflamalarını ve tedavi stratejilerinin sunulması amaçlandı.

🔖

Cite This Article

ÖZKAYA, A., YAZICI, A. T., DEMİROK, A. (2012). Juxtafoveal telangiectasis. Retina-Vitreus, Cilt: 20 - Sayı: 1, 1–12. https://ajindex.com/articles/305057

References (12)

  1. Reese AB. Telangiectasis of the retina and Coats’disease. Am J Ophthalmol 1956;42:1-8
  2. Gass JD, Owawaka RT. Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 1982;10:769-80
  3. Gass JD, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 1993;100:1936-46 4. Novilaty SR, Al-Shamsi HN, Al-Khars W. Idiopathic juxtafoveolar retinal telangiectasis: A current Review. Middle East Afr J Ophthalmol 2010;17:224-41
  4. Yannuzzi LA, Bardal AM, Freund KB, Cet al. Idiopathic macular telangiectasia. Arch Ophthalmol 2006;124:450-60
  5. Wong WT, Forooghian F, Majumdar Z, et al. Fundus autofluorescence in type 2 idiopathic macular telangiectasia: Correlation with optical coherence tomography and microperimetry. Am J Ophthalmol 2009;148:573-83
  6. Kadayıfçılar S. İdiyopatik parafoveal telanjiektazi. Ret-Vit 2004;12:152-7 8. Sanchez JG, Garcia RA, Wu L, et al. Optical coherence tomography characteristics of group 2A idiopathic parafoveal telangiectasis. Retina 2007;27:1214-20 9. Shields JA, Shields CL, Honavar SG, et al. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol 2001;13:561-71
  7. Smithen LM, Brown GC, Brucker AJ, et al. Coats’disease diagnosed in adulthood. Ophthalmology 2005;112:1072-8
  8. Paunescu LA, Ko TH, Duker JS, Chan A, Drexler W, Schuman JS, Fujimoto JG. Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography. Ophthalmology 2006;113:48-57
  9. Esgin S, Karacaoğlu O, Erda S. Fasioskapulohumeral Musküler Distrofili bir olguda, Lagoftalmi ve Retinal Telanjiektaziler Ret-Vit 2004;3:200-2 13. Parodi MB, Iacono P, Ravalico G. Subretinal neovascular membrane associated with type 2a idiopathic juxtafoveolar telangiectasisin pseudoxanthoma elasticum. Graefes Arch Clin Exp Ophthalmol 2007;245:612-5
  10. Stoffelns BM, Schoepfer K, Kramann C. [Idiopathic macular telangiectasia - follow-up with and without laser photocoagulation]. Klin Monbl Augenheilkd 2010;227:252-6
  11. Hirano Y, Yasukawa T, Usui Y, et al. Indocyanine green angiography-guided laser photocoagulation combined with sub-Tenon’s capsule injection of triamcinolone acetonide for idiopathic macular telangiectasia. Br J Ophthalmol 2010;94:600-5
  12. Kotoula MG, Chatzoulis DZ, Karabatsas CH, et al. Resolution of macular edema in idiopathic juxtafoveal telangiectasis using PDT. Ophthalmic S